InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-21.3%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the detailed record of transactions filed by Kantoff Aaron, 董事. Insider active across 3 companies, notably Centessa Pharmaceuticals plc. Cumulatively, 8 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €190k. Activity tracked since 18 November 2021. The latest transaction was disclosed on 24 October 2025 (Don). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kantoff Aaron
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
3,166 股Common StockSEC:0001862734-26-000002:0
88,281 股Common StockSEC:0001862734-25-000006:0
5,000 股0Common StockSEC:0001862734-25-000004:0
37,890 股@ US$0.134.8% 占其流量Common StockSEC:0001415889-25-023997:0
3,167 股Common StockSEC:0001578563-25-000201:0
7,500 股@ US$11.86100.0% 占其流量Common StockSEC:0001209191-23-053674:0
标准退出：2024年1月22日 (T+90)
37,891 股Common StockSEC:0001209191-23-053397:0
10,000 股@ US$11.985100.0% 占其流量Ordinary SharesSEC:0000899243-21-045321:0
标准退出：2022年2月16日 (T+90)
8 条申报中的 8 条
About Kantoff Aaron
KANTOFF AARON is Administrateur at Tourmaline Bio, Inc., Avalo Therapeutics, Inc. and Centessa Pharmaceuticals plc. Across 8 filings in total, the 8 sampled filings cover the period from 2021-11-18 to 2026-03-31, with EUR 189815 of buys and EUR 0 of sells, and the most common transaction nature is Levée d'options.
